Accueil / Communiqués / Akebia Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference

Akebia Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference

Wednesday, January 2nd 2019 at 12:00pm UTC

CAMBRIDGE, Mass.–(BUSINESS WIRE)– Akebia
Therapeutics
, Inc. (Nasdaq: AKBA), a biopharmaceutical company
focused on the development and commercialization of therapeutics for
patients with kidney disease, today announced that its President and
Chief Executive Officer, John P. Butler, will present at the 37th
Annual J.P. Morgan Healthcare Conference on Wednesday, January 9, 2019
at 9:30 a.m. Pacific Time at the Westin St. Francis in San Francisco.

A live webcast of the presentation will be available on the company’s
website at www.akebia.com.
To access, please log onto the Akebia website at least 15 minutes prior
to the webcast to ensure adequate time for any software downloads that
may be required. A replay of the webcast will be available on Akebia’s
website following the conference.

About Akebia Therapeutics

Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical
company focused on the development and commercialization of therapeutics
for patients with kidney disease. The company was founded in 2007 and is
headquartered in Cambridge, Massachusetts. For more information, please
visit our website at www.akebia.com,
which does not form a part of this release.

Contacts

Akebia Therapeutics Contact:
Argot Partners
Melissa
Forst / Maghan Meyers
(212) 600-1902

Source: Akebia Therapeutics, Inc.


Voir aussi

Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

Friday, January 18th 2019 at 9:05pm UTC WALTHAM, Mass.–(BUSINESS WIRE)– Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today …